Advertisement

Topics

Companies Related to "Substantial Doubt About Maven" [Most Relevant Company Matches] RSS

11:45 EDT 24th September 2017 | BioPortfolio

Here are the most relevant search results for "Substantial Doubt About Maven" found in our extensive corporate database of over 50,000 company records.

Showing "Substantial Doubt About Maven" Companies 1–25 of 216

Wednesday 5th July 2017

New York & Company

New York & Company, Inc. is a leading omni-channel women’s fashion retailer designing on-trend and versatile collections at a great value. The specialty retailer, first incorporated in 1918, has grown to now operate over 400 retail and outlet locations nationwide while also growing a substantial e-commerce business. Its branded merchandise, including ...


Edgemont Capital Partners, L.P.

Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is a specialty M&A advisory firm dedicated to providing the highest quality strategic advisory and capital raising services to healthcare companies. The firm's deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise allows Edgemont to address healthca...

Tuesday 13th June 2017

Fitzpatrick, Cella, Harper & Scinto

Founded in 1971, Fitzpatrick, Cella, Harper & Scinto has grown to over 150 attorneys practicing all aspects of intellectual property law, including patents, trademarks, copyrights, unfair competition, and trade secrets. Our offices in New York, Washington D.C. and Costa Mesa, California, serve a diverse national and international clientele. Regardless of the size of a matter, we are committed to d...


Wednesday 24th May 2017

Nomad Health

Nomad Health is a technology company that is simplifying the $15 billion temporary healthcare staffing industry. The company has built the first online marketplace that enables clinicians and the institutions that hire them to find each other and transact directly, without a broker. Nomad Health brings substantial cost savings, dynamic pricing, and a strea...

Tuesday 16th May 2017

Smith & Nephew

Smith & Nephew develops and markets advanced medical devices that help healthcare professionals treat patients more effectively – and patients get back to their normal lives faster. Our dedicated Global Business Units – Orthopaedic Reconstruction, Orthopaedic Trauma & Clinical Therapies, Endoscopy and Advanced Wound Management – specialise in innovative, cost-effective products that meet pre...

Thursday 11th May 2017

MEDICITY

Medicity was launched in 1998 by a team of healthcare IT professionals who believed it should be easier for physicians and other providers to access a unified electronic view of the information they need to facilitate timelier, more informed care decision.z!The proliferation of Internet connections made such a view not only feasible but likely in a short period of time. Other entrepreneurs, like S...

Wednesday 3rd May 2017

Rigontec

Rigontec is the leader in RIG-I targeting therapeutics. Utilizing our proprietary RIG-I agonist platform, we harness one of the most essential pathways in the innate immune system to pioneer a novel immuno-oncology treatment approach. Rigontec’s proprietary agonists specifically activate RIG-I, inducing both immediate and long-term anti-tumor immunity...

Thursday 20th April 2017

Rasna Therapeutics, Inc.

Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the high unmet need that exists for leukemias. Rasna’s primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5-year survival rate of only about 25% and very poor prospects for long-term survival of patients. The comp...

Wednesday 12th April 2017

Rasna Therapeutics , Inc.

Rasna Therapeutics, Inc. is a biotechnology company focused primarily on the high unmet need that exists for leukemias. Rasna’s primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5-year survival rate of only about 25% and very poor prospects for long-term survival of patients. The company has a balanced...

Thursday 16th March 2017

Centrexion Therapeutics, Corp.

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and ...

Monday 27th February 2017

BTG Plc

BTG in-licenses, develops and commercialises pharmaceuticals, targeting neurological and other disorders. The company has a substantial and growing revenue stream of royalties from out-licensed products, a broad internal pipeline of development programmes and a pipeline of licensed programmes. Listed on the London Stock Exchange since 1995 (LSE: BGC), the company employs around 70 people in Lond...

Wednesday 30th November 2016

A1M Pharma

A1M Pharma develops a diagnostic method and a novel treatment for the damaging effects of pre-eclampsia, a condition that affects around 10 million pregnant women worldwide. This disorder is responsible for 76,000 maternal and 500,000 infant deaths each year. It is also the cause of 15 per cent of all premature births. Currently, there is no predictive diagnostic method or treatment for impairme...

Wednesday 30th March 2016

Centrexion Therapeutics

Centrexion Therapeutics, Inc., is focused on developing and commercializing new, non-opioid and non-surgical treatments for moderate to severe chronic pain. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and aims to develop new, safer and more effective therapies that overcome the li...

Wednesday 9th March 2016

4Tech Inc.

4Tech Inc. (www.4techtricuspid.com) is incorporated in Delaware, USA, with operations in Galway, Ireland (4Tech Cardio Ltd). 4Tech has developed a proprietary transcatheter solution for the treatment of TR. Because of its unique anchoring and tensioning mechanism, the 4Tech TriCinch™ System for Transcatheter Tricuspid Valve Repair allows a simple and ...

Monday 22nd February 2016

Excelerate

Excelerate is a joint venture between Cleveland Clinic and VHA designed to deliver significant and substantial savings to health care organizations through a provider-led, physician-engaged sourcing company. Excelerate achieves this through executing data-driven, market-leading contracts, clinical utilization guidelines designed to decrease clinical variat...

Thursday 7th January 2016

Pursuit Vascular

Headquartered in Maple Grove, Minnesota, Pursuit Vascular, Inc. is developing a family of innovative single-use products designed to protect patients from acquiring life-threatening infections associated with long-term catheter and port use. Routine use of these products could result in substantial savings to the health care system. For more information vi...

Monday 7th September 2015

Relief Therapeutics

Peripheral neuropathies are a group of conditions characterized by degeneration of peripheral motor, sensory, or autonomic nerves. Degeneration of peripheral nerves causes a wide variety of symptoms and signs ranging from intractable pain, numbness and tingling to potentially impairment of strength, balance, and coordination. Neuropathies develop as a resu...

Wednesday 18th March 2015

Nimbus Therapeutics

Nimbus Therapeutics harnesses the power of computational chemistry to design breakthroughs for the treatment of substantial and underserved human diseases. The company’s focus on metabolic diseases, cancer and immune-inflammatory disorders is driven by its selection of well validated targets that have proven intractable to the approaches taken by othe...

Monday 24th November 2014

CardiAQ Valve Technologies, Inc.

Privately held CardiAQ, headquartered in Irvine, Calif., has developed a proprietary Transcatheter Mitral Valve (TMV) Implant that can be delivered through multiple delivery systems, including both Trans-femoral and Trans-apical. Through its unique anchoring mechanism that engages and utilizes the patient’s native mitral valve anatomy, physicians will...

Tuesday 16th September 2014

Libero Holdings

Libero Holdings is a privately held investment group that funds early stage companies in the medical device marketplace. Its focus is to partner with entrepreneurs and industry professionals to develop and commercialize proprietary technologies. Libero looks to invest in technologies that will offer substantial innovation, differentiation and clinical impr...

Wednesday 27th August 2014

Biosceptre

Biosceptre has identified a pan-cancer target, present in many cancer types, and importantly not found in healthy tissue. Early research and initial evidence suggest that drugs directed at the nf-P2X7 target have the potential to redefine cancer therapy. The Company has raised AUD33m and will be raising further capital through both existing and new investo...

Varsity Healthcare Partners

Varsity Healthcare Partners (VHP) is a Los Angeles and Stamford (CT) based private investment firm serving primarily family and small institutional investors by originating, acquiring, and growing market-leading healthcare provider platforms within selected non-discretionary and/or cost saving healthcare verticals. VHP’s principals bring extensive hea...

Blood Centers of America, Inc.

BCA is a member-owned organization comprised of independent blood centers geographically dispersed throughout North America. Along with their core business of providing a substantial portion of the U.S. blood supply, BCA members provide a myriad of other services in cell therapies, blood management, therapeutic apheresis, tissue and cord blood banking. Mem...

Prothena Biosciences Inc

Prothena Corporation plc (Nasdaq: PRTA) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel antibodies that are directed towards diseases that involve protein misfolding or cell adhesion. Prothena Pharmaceuticals The Company’s work in protein misfolding could result in therapies to treat a number of diseases, including AL (prima...

Ario Pharma Ltd

ario pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1 inhibitor, in two Phase 2 clinical trials that will read out in 2014. The company is managed by a highly experienced development team and supported by world-renowned KOLs in respiratory disease. Co...


More From BioPortfolio on "Substantial Doubt About Maven"

Quick Search
Advertisement
 

Corporate Database Quicklinks